The Effect of Losartan Treatment on Nitroglycerin Tolerance in Rats

张建梅,陈永红,王晓红,齐永芬,唐朝枢

DOI: https://doi.org/10.3760/j.issn:0578-1310.2001.08.008

2001-01-01

Abstract:Objective Nitroglycerin (NTG)and other nitrovasodilators have been widely used to treat congenital heart disease,primary cardiomyopathy and congestive heart failure in pediatrics. However,during the long\|term administration,the hemodynamic and anti\|ischemic efficacy of NTG is rapidly attenuated by the development of tolerance.This study aimed at investigating whether angiotensin Ⅱreceptor antagonist losartan could improve NTG tolerance in vivo. Methods Losartan potassium was purchased from Trademark of EI,Du Pont de Nemours and Company,Delaware,USA.Endothelin I (ET\|I) radioimmunoassay reagent was purchased from Phoenix Pharmaceuticals Inc. NTG patch (16 mg/patch) was purchased from Zhuhai Schwarz Pharma Company Limited. Trasylol was made by Bayer AG, Germany UK Subsidiary.Male Wistar rats weighing 250\|300 g were provided by Experimental Animal Center of Peking University. A total of 28 rats were divided into 4 groups.(1) Control group( n =10):No drugs were used.(2)NTG group( n =6):NTG tolerance animal model was prepared according to Munzel T and Urmlia, et al. A region between scapulae was shaved and NTG patch (0.05mg/h)was applied to the skin. The treatment period started between 8 AM and 10 AM and NTG patch was changed each morning for the ensuing 2 days. (3)losartan group( n =6):losartan 10 mg/(kg·d) was given by gavage for 2 days. (4)NTG plus losartan group( n =6):losartan 10 mg/(kg·d) was given by gavage for 2 days and simultaneously NTG patch treatment was given the same as NTG group. Results Hypotensive responses in the 4 groups before sodium nitroprusside (SNP) showed no significant difference. Hypotensive responses after SNP 20 ug/kg, iv were different among 4 groups. The percentage of hypotensive response to SNP was decreased in NTG group(21±4)% compared with that in control group(34±4)%, P 0.01. The hypotensive response was enhanced in NTG plus losartan group (31±5)% compared with that in NTG group, P 0.01.The maximal vessel relaxation induced by SNP was the same in 4 different groups but the highest EC 50 (concentration which produces 50% of the maximal response to SNP) was found in NTG group [(33.89±10.86)nmol/l, P 0.01].The ET\|1 amounts in plasma and vascular tissue were markedly increased by 54% and 60% in NTG group compared with those in control group ( P 0.01).In contrast to NTG proup the ET\|1 amounts in plasma and vascular tissue were decreased by 30% and 37% in NTG plus losartan group ( P 0.01).Conclusion The results of the study supported that angiotensin Ⅱ receptor antagonist losartan seemed to be a possible candidate medicine to prevent from NTG tolerance in vivo.